Clinical Trial Update: Vitamine D in Drug Resistant Epilepsy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Vitamin D as an adjunct therapy for drug-resistant epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Epilepsy

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Centre Hospitalier St Anne | Conditions: Drug Resistant Epilepsy | Phase 3 | Status: COMPLETED